Endocrine therapy alone in older adults with good prognosis estrogen receptor-positive breast cancer

被引：0
|
作者：
Israel, Irene [1 ]
Aft, Rebecca [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1147322
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [31] Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor-positive breast cancer
    Chen, Weilin
    Wu, Jiayi
    Zhu, Yifei
    Huang, Jiahui
    Chen, Xiaosong
    Huang, Ou
    He, Jianrong
    Li, Yafen
    Chen, Weiguo
    Shen, Kunwei
    Zhu, Li
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [32] Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
    Marta Engelking
    Schelomo Marmor
    Mohamad Burjak
    Madeleine Hinojos
    Whitney Lloyd
    Kayla M. Switalla
    Todd M. Tuttle
    Breast Cancer Research and Treatment, 2023, 198 : 187 - 195
  • [33] Avoidance of Negative Results in Adjuvant Endocrine Therapy Trials for Estrogen Receptor-Positive Breast Cancer Reply
    Smith, Ian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2719 - +
  • [34] Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
    Ellis, Matthew J.
    Tao, Yu
    Luo, Jingqin
    A'Hern, Roger
    Evans, Dean B.
    Bhatnagar, Ajay S.
    Ross, Hilary A. Chaudri
    von Kameke, Alexander
    Miller, William R.
    Smith, Ian
    Eiermann, Wolfgang
    Dowsett, Mitch
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) : 1380 - 1388
  • [35] Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
    Zahavi, Tamar
    Salmon-Divon, Mali
    Salgado, Roberto
    Elkin, Michael
    Hermano, Esther
    Rubinstein, Ariel M.
    Francis, Prudence A.
    Di Leo, Angelo
    Viale, Giuseppe
    de Azambuja, Evandro
    Ameye, Lieveke
    Sotiriou, Christos
    Salmon, Asher
    Kravchenko-Balasha, Nataly
    Sonnenblick, Amir
    NPJ BREAST CANCER, 2021, 7 (01)
  • [36] A review of endocrine therapy in early estrogen receptor-positive breast cancer by St. Gallen Breast Cancer Conference 2021
    Zhou, Yan
    Yang, Jin
    TRANSLATIONAL BREAST CANCER RESEARCH, 2021, 2
  • [37] The Optimal Duration of Endocrine Therapy in Hormone Receptor-Positive Breast Cancer
    Sledge, George W., Jr.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (06) : 383 - 404
  • [38] Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
    Tamar Zahavi
    Mali Salmon-Divon
    Roberto Salgado
    Michael Elkin
    Esther Hermano
    Ariel M. Rubinstein
    Prudence A. Francis
    Angelo Di Leo
    Giuseppe Viale
    Evandro de Azambuja
    Lieveke Ameye
    Christos Sotiriou
    Asher Salmon
    Nataly Kravchenko-Balasha
    Amir Sonnenblick
    npj Breast Cancer, 7
  • [39] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    Current Oncology Reports, 2023, 25 : 689 - 698
  • [40] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
12345